申请人:Imperial Chemical Industries Limited
公开号:US04167569A1
公开(公告)日:1979-09-11
The invention concerns 3,4-dihydropyrimido [1,2-a]benzimidazole derivatives bearing one or more substituents at positions 6, 7, 8 or 9; processes for their preparation and manufacture; and pharmaceutical compositions thereof. The compounds inhibit the aggregation of blood-platelets and may be used in vivo, in the treatment or prophylaxis of thrombosis or occlusive vascular disease, or in vitro, in helping to stabilize preparations of blood platelets. Representative compounds of the invention are 7- and 8- acetyl-3,4-dihydropyrimido[1,2-a]benzimidazol-2(1H)-one.
这项发明涉及3,4-二氢嘧啶并[1,2-a]苯并咪唑衍生物,在6、7、8或9位置带有一个或多个取代基;它们的制备和制造过程;以及它们的药物组合物。这些化合物抑制血小板的聚集,可在体内用于治疗或预防血栓形成或闭塞性血管疾病,或在体外用于帮助稳定血小板制剂。该发明的代表性化合物是7-和8-乙酰基-3,4-二氢嘧啶并[1,2-a]苯并咪唑-2(1H)-酮。